Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 3/20 | 0.43 |
| ▸ | CNR1 | P21554 | 4/20 | 0.39 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.35 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.35 |
| ▸ | CCR4 | P51679 | 1/20 | 0.35 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.34 |
| ▸ | THRA | P10827 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | PDE2A | O00408 | 2/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6203747 | 0.99 | CRHR1 (0.44) | CRHR1CNR1LIMK1LIMK2CCR4 | |
| SCHEMBL6201218 | 0.92 | CRHR1 (0.42) | CRHR1CNR1LIMK1LIMK2CCR4 | |
| SCHEMBL6204093 | 0.92 | CRHR1 (0.42) | CRHR1CNR1LIMK1LIMK2CCR4 | |
| SCHEMBL6204591 | 0.91 | CRHR1 (0.43) | CRHR1CNR1LIMK1LIMK2CCR4 | |
| SCHEMBL6203274 | 0.88 | CNR1 (0.40) | CRHR1CNR1LIMK1LIMK2CCR4 | |
| SCHEMBL6202389 | 0.87 | CRHR1 (0.44) | CRHR1PTPN11THRATHRB | |
| SCHEMBL6204985 | 0.87 | CRHR1 (0.44) | CRHR1PTPN11THRATHRB | |
| SCHEMBL6203602 | 0.86 | CRHR1 (0.45) | CRHR1THRATHRBKDM4EMAPT | |
| SCHEMBL5432749 | 0.83 | CRHR1 (0.45) | CRHR1CNR1LIMK1MAPK14CHRNA7 | |
| SCHEMBL5437646 | 0.82 | CRHR1 (0.48) | CRHR1LIMK1LIMK2MAPK14CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1554258-A1 | 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS | NEUROGEN CORPORATION (US) | 2005-07-20 | — | — | EP | claimed |
| WO-2004018437-A1 | 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS | NEUROGEN CORPORATION (US) | 2004-03-04 | — | — | WO | claimed |